Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
NEJM 378:708-718, Albers, G.W.,et al, 2018
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
NEJM 372:1019-1030, Goyal, M.,et al, 2015
Interobserver Variability of Grading Scales for Aneurysmal Subarachnoid Hemorrhage
Stroke 42:1546-1549, Degen, L.A.R.,et al, 2011
Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008
Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007
How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007
Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994
Measuring Physical Impairment and Disability with the Chedoke-McMaster Stroke Assessment
Stroke 24:58-63, Gowland,C.,et al, 1993
Interobserver Reliability Between Neurologists in Training of Parkinson's Disease Rating Scales
Movement Disorders 6:330-335, Geminiani,G.,et al, 1991
Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989
Interrater Reliability in Assessing Functional Systems and Disability on the Kurtzke Scale in Multiple Sclerosis
Arch Neurol 45:746-748, Amato,M.P.,et al, 1988
Interobserver Agreement for the Assessment of Handicap in Stroke Patients
Stroke 19:604-607, vanSwieten,J.C.,et al, 1988
Graded Neurologic Scale for Use in Acute Hemispheric Stroke Treatment Protocols
Stroke 18:665-669, Adams,R.J.,et al, 1987